Anna Veres-Székely

Prof. Anna Veres-Székely

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Behavioral and Brain Functions
Verified
Journal Article
Open access
PDF file
ZNZsofia Nemoda
Zsofia Nemoda
KLKarlen Lyons-Ruth
Karlen Lyons-Ruth
AVAnna Veres-Székely
Anna Veres-Székely
EBEszter Bertha
Eszter Bertha
GFGabor Faludi
Gabor Faludi
MSMaria Sasvari-Szekely
Maria Sasvari-Szekely
In the development of borderline personality disorder (BPD) both genetic and environmental factors have important roles. The characteristic affective disturbance and impulsive aggression are linked to imbalances in the central serotonin system, and most of the genetic association studies focused on serotonergic candidate genes. However, the efficacy of dopamine D2 receptor (DRD2) blocking antipsychotic drugs in BPD treatment also suggests involvement of the dopamine system in the neurobiology of BPD.

18 January 2012 in American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Verified
Journal Article
Closed access
PDF file
GVGabor Varga
Gabor Varga
AVAnna Veres-Székely
Anna Veres-Székely
Peter AntalPeter Antal
Peter Antal
PSPeter Sarkozy
Peter Sarkozy
ZNZsofia Nemoda
Zsofia Nemoda
MSMaria Sasvari‐Szekely
Maria Sasvari‐Szekely

25 May 2010 in International Journal of Clinical and Experimental Hypnosis
Verified
Journal Article
Closed access
AVAnna Veres-Székely
Anna Veres-Székely
RKReka Kovacs-Nagy
Reka Kovacs-Nagy
ÉBÉva I. Bányai
Éva I. Bányai
AGAnna C. Gősi-Greguss
Anna C. Gősi-Greguss
KVKatalin Varga
Katalin Varga
MSMaria Sasvari-Szekely
Maria Sasvari-Szekely
Previous studies implicate involvement of dopaminergic systems in hypnotizability and report association with the COMT Val158Met single nucleotide polymorphism (SNP, rs4680) demonstrating the Val/Met heterozygotes as the most hypnotizable group using the Stanford Hypnotic Susceptibility Scale. This study replicates that association using an independent sample of 127 healthy Hungarian young adults and the Waterloo-Stanford Group C Scale of Hypnotic Susceptibility. Significant association (p = .016) was found between the COMT genotypes and hypnotizability, with a clear additive effect of the Val allele: Hypnotizability scores were highest in Val/Val (5.9), intermediate in Val/Met (4.7), and lowest in Met/Met (4.1). Differences between these results and those of previous studies support recent findings suggesting an inverted-U-shaped relation between dopamine level in the prefrontal cortex and cognitive functioning. The present study replicates association of COMT Val158Met SNP and hypnotizability and stresses the importance of mediating factors, such as group vs. individual inductions.

19 August 2009 in BMC Medical Genetics
Verified
Journal Article
Open access
PDF file
GNGeza Nagy
Geza Nagy
RKReka Kovacs-Nagy
Reka Kovacs-Nagy
EKEva Kereszturi
Eva Kereszturi
ASAniko Somogyi
Aniko Somogyi
AVAnna Veres-Székely
Anna Veres-Székely
MSMaria Sasvari-Szekely
Maria Sasvari-Szekely
Background: Hypoxia inducible factor-1 alpha (HIF-1α) is a transcription factor that plays an important role in neo-vascularisation, embryonic pancreas beta-cell mass development, and beta cell protection. Recently a non synonymous single nucleotide polymorphism (g.C45035T SNP, rs11549465) of HIF-1α gene, resulting in the p.P582S amino acid change has been shown to be associated with type 2 diabetes (T2DM) in a Japanese population. Our aim was to replicate these findings on a Caucasian (Hungarian) population, as well as to study whether this genetic effect is restricted to T2DM or can be expanded to diabetes in general. Methods: A large Caucasian sample (N = 890) was recruited including 370 T2DM, 166 T1DM and 354 healthy subjects. Genotyping was validated by two independent methods: a restriction fragment analysis (RFLP) and a real time PCR using TaqMan probes. An overestimation of heterozygotes by RFLP was observed as a consequence of a nearby SNP (rs34005929). Therefore genotyping results of the justified TaqMan system were accepted. The measured genotype distribution corresponded to Hardy-Weinberg equilibrium (P = 0.740) Results: As the TT genotype was extremely rare in the population (0.6% in clinical sample and 2.5% in controls), the genotypes were grouped as T absent (CC) and T present (CT and TT). Genotype-wise analysis showed a significant increase of T present group in controls (24.0%) as compared to patients (16.8%, P = 0.008). This genetic effect was demonstrated in the separated samples of type 1 (15.1%, P = 0.020), and also in type 2 (17.6%, P = 0.032) diabetes. Allele-wise analysis gave identical results showing a higher frequency of the T allele in the control sample (13.3%) than in the clinical sample (8.7%, P = 0.002) with similar results in type 1 (7.8%, P = 0.010) and type 2 (9.1%, P = 0.011) diabetes. The odds ratio for diabetes (either type 1 or 2) was 1.56 in the presence of the C allele. Conclusion: We confirmed the protective effect of a rare genetic variant of HIF-1α gene against type 2 diabetes in a Caucasian sample. Moreover we demonstrated a genetic contribution of the same polymorphism in type 1 diabetes as well, supporting a possible overlap in pathomechanism for T2DM and a T1DM.

6 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EKEszter Kotyuk
Eszter Kotyuk
GKGergely Keszler
Gergely Keszler
NNNora Nemeth
Nora Nemeth
ZRZsolt Ronai
Zsolt Ronai
MSMaria Sasvari-Szekely
Maria Sasvari-Szekely
AVAnna Veres-Székely
Anna Veres-Székely
Glial cell line-derived neurotrophic factor (GDNF) is a neurotrophic factor for dopaminergic neurons with promising therapeutic potential in Parkinson's disease. A few association analyses between GDNF gene polymorphisms and psychiatric disorders such as schizophrenia, attention deficit hyperactivity disorder and drug abuse have also been published but little is known about any effects of these polymorphisms on mood characteristics such as anxiety and depression. Here we present an association study between eight (rs1981844, rs3812047, rs3096140, rs2973041, rs2910702, rs1549250, rs2973050 and rs11111) GDNF single nucleotide polymorphisms (SNPs) and anxiety and depression scores measured by the Hospital Anxiety and Depression Scale (HADS) on 708 Caucasian young adults with no psychiatric history. Results of the allele-wise single marker association analyses provided significant effects of two single nucleotide polymorphisms on anxiety scores following the Bonferroni correction for multiple testing (p = 0.00070 and p = 0.00138 for rs3812047 and rs3096140, respectively), while no such result was obtained on depression scores. Haplotype analysis confirmed the role of these SNPs; mean anxiety scores raised according to the number of risk alleles present in the haplotypes (p = 0.00029). A significant sex-gene interaction was also observed since the effect of the rs3812047 A allele as a risk factor of anxiety was more pronounced in males. In conclusion, this is the first demonstration of a significant association between the GDNF gene and mood characteristics demonstrated by the association of two SNPs of the GDNF gene (rs3812047 and rs3096140) and individual variability of anxiety using self-report data from a non-clinical sample.

7 October 2010 in Genes, Brain and Behavior
Verified
Journal Article
Closed access
PDF file
AVAnna Veres-Székely
Anna Veres-Székely
DBD. A. Balota
D. A. Balota
JDJ. M. Duchek
J. M. Duchek
ZNZ. Nemoda
Z. Nemoda
Andrea VereczkeiAndrea Vereczkei
Andrea Vereczkei
MSM. Sasvari-Szekely
M. Sasvari-Szekely